Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 1/28/2026ADB Provides CNY 141M Loan to Support China's Community-Based Pharma ...
  • 1/28/2026China Issues Trial Guidance on Pharmaceutical Research for Preventive ...
  • 1/27/2026Lisata Regains Greater China Rights to Pancreatic Cancer Candidate Ahe...
  • 1/27/2026Insilico Expands AI-Driven Cardiometabolic Pipeline with $120M Qilu Co...
  • 1/27/2026NMPA Adopts ICH M14 Guideline on Real-World Evidence for Drug Safety E...
  • 1/27/2026Boehringer Ingelheim Strikes €1.05B Deal With Simcere for Preclinical...
  • 1/26/2026Neowise Raises Over CNY 200M in Series B to Advance TCR-T Therapies fo...
  • 1/26/2026HealZen Unveils Global Strategic Partnership to Advance Degrader-Antib...
  • 1/26/2026BMS Accelerates Global Development of PD-L1/VEGF Bispecific After Biot...
  • 1/26/2026Dizal Pharma's Hong Kong IPO Application Accepted
  • 1/23/2026China Grants Conditional Approval to First Hepatitis D Treatment
  • 1/23/2026Fosun Pharma Moves to Spin Off Vaccine Unit for Hong Kong IPO
  • 1/23/2026Livzon Moves to Acquire Majority Stake in Vietnam's Imexpharm
  • 1/23/2026Gene Key Secures Over CNY 100M to Accelerate iNKT Cell Therapy Develop...
  • 1/22/2026Hua Medicine Targets Global Diabetes Growth with Non-GLP-1 Strategy
  • 1/22/2026Corxel Raises Up to $287M to Push GLP-1 Pill Toward Global Markets
  • 1/22/2026Bangshun Pharma Files for Hong Kong IPO
  • 1/22/2026T-MAXIMUM Unveils First Human Data for CRISPR-Edited CAR-T
  • 1/21/2026Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expan...
  • 1/21/2026NewDEL Raises A+ Round Led by XtalPi to Accelerate DEL-AI Drug Develop...
  • 1/21/2026Harbour BioMed Takes Strategic Stake in Spruce Biosciences
  • 1/20/2026Ellipses In-Licenses First-in-Class B7H3 ADC from China's Innolake
  • 1/20/2026Insilico and Hygtia Therapeutics Forge Global Alliance on AI-Discovere...
  • 1/20/2026GSK to Buy RAPT Thera for $2.2B, Securing China-Partnered Anti-IgE Ass...
  • 1/19/2026Biyo Secures ~CNY 100M in Pre-A Funding as Lead Migraine Biologic Adva...
  • 1/19/2026ABM Thera Licenses MEK1/2 Inhibitor ABM-168 to Mosaica Medicines for G...
  • 1/19/2026Henlius Biotech Secures Global Rights to IL-1RAP Antibody from U-mab B...
  • 1/19/2026AstraZeneca Acquires Full Global Rights to AbelZeta’s GPC3 Armored CA...
  • 1/16/2026AmCham China Survey Shows Resilience and Improving Performance Among U...
  • 1/16/2026HEC Pharma Wins China Approval for Olorigliflozin in Type 2 Diabetes
  • Page:1/25 Total number of articles:731: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group